Differential morphine tolerance development in the modulation of macrophage cytokine production in mice

Journal of Leukocyte Biology

Volumn 72, Issue 1, 2002, Pages 43-48

  Limiroli, Elena ^a   Gaspani, Leda ^a   Panerai, Alberto E ^a   Sacerdote, Paola ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Antinociception; IL 10; IL 12; Naltrexone; TNF

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; LIPOPOLYSACCHARIDE; MORPHINE; NALTREXONE; THIOGLYCOLIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE RESPONSE; DRUG EFFECT; HUMORAL IMMUNITY; IMMUNOMODULATION; MALE; MORPHINE TOLERANCE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL;

ANIMALIA; MURINAE;

EID: 0036659129     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.72.1.43     Document Type: Article

References (39)

1. Lysle, D. T., Coussons, M. E., Watts, V. J., Bennet, E. H., Dykstra, L. A. (1993) Morphine-induced alterations of immune status: dose dependency, compartment specificity and antagonism by naltrexone. J. Pharmacol. Exp. Ther. 265, 1071-1078.
2. Sacerdote, P., Manfredi, B., Mantegazza, P., Panerai, A. E. (1997) Antinociceptive and immunosuppressive effects of opiate drugs: a structure-related activity study. Br. J. Pharmacol. 121, 834-840.
3. Eisenstein, T. K., Hillburger, M. E. (1998) Opioid modulation of immune responses: effects on phagocyte and lymphoyd cell populations. J. Neuroimmunol. 83, 36-44.
4. Pacifici, R., Di Carlo, S., Bacosi, A., Pichini, S., Zuccaro, P. (2000) Pharmacokinetics and cytokine production in heroin and morphine-treated mice. Int. J. Immunopharmacol. 22, 603-614.
5. Sacerdote, P., Manfredi, B., Gaspani, L., Panerai, A. E. (2000) The opioid antagonist naloxone induces a shift from type 1 cytokine pattern to type 2 cytokine pattern in Balb/cJ mice. Blood 95, 2031-2036.
6. Bryant, H. U., Roudebush, R. E. (1990) Suppressive effects of morphine pellet implants on in vivo parameters of immune function. J. Pharmacol. Exp. Ther. 255, 410-414.
7. Carr, D. J., France, C. P. (1993) Immune alterations in morphine-treated Rhesus monkeys. J. Pharmacol. Exp. Ther. 267, 9-15.
8. Tubaro, E., Santiangeli, C., Belogi, L., Borelli, G., Cavallo, G., Croce, C., Avico, U. (1987) Methadone vs morphine: comparison of their effect on phagocytic functions. Int. J. Immunopharmacol. 9, 79-88.
9. Rojavin, M., Szabo, I., Bussiere, J. L., Rogers, T. J., Adler, M. W., Eisenstein, T. K. (1993) Morphine treatment in vitro or in vivo decreases phagocytic functions of murine macrophages. Life Sci. 53, 997-1006.
10. Miller, J. A., Hopkins, S. J., Luheshi, G. N. (1997) Sites of action of IL-1 in the development of fever and cytokine responses to tissue inflammation in the rat. Br. J. Pharmacol. 120, 1274-1279.
11. Beutler, B., Cerami, A. (1989) The biology of cachectin/TNF - a primary mediator of the host response. Annu. Rev. Immunol. 7, 625-655.
12. Trincheri, G. (1995) Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen specific adaptive immunity. Annu. Rev. Immunol. 13, 251-276.
13. Mosman, T. R., Sad, S. (1996) The expanding universe of T-cell subsets; Th1, Th2 and more. Immunol. Today 17, 138-146.
14. Moore, K. W., O'Garra, A., De Waal Malefyt, R., Vieira P., Mosmann, T. R. (1993) Interleukin-10. Annu. Rev. Immunol. 11, 165-190.
15. Bianchi, M., Maggi, R., Pimpinelli, F., Rubino, T., Parolaro, D., Poli, V., Ciliberto, G., Panerai, A. E., Sacerdote, P. (1999) Presence of a reduced opioid response in interleukin-6 knock out mice. Eur. J. Neurosci. 11, 1501-1507.
16. Hilburger, M. E., Adler, M. W., Rogers, T. J., Eisenstein, T. K. (1997) Morphine alters macrophage and lymphocyte populations in the spleen and peritoneal cavity. J. Neuroimmunol. 80, 106-114.
17. Singhal, P. C., Sharma, P., Kapasi, A. A., Reddy, K., Franki, N., Gibbons, N. (1998) Morphine enhances macrophage apoptosis. J. Immunol. 160, 1886-1893.
18. Tubaro, E., Borelli, G., Croce, C., Cavallo, G., Santiangeli, C. (1983) Effect of morphine on resistance to infection. J. Infect. Dis. 148, 656-666.
19. Peng, X. P., Mosser, D. M., Adler, M. A., Rogers, T. J., Meissler, J. J., Eisenstein, T. B. (2000) Morphine enhances interleukin-12 and the production of proinflammatory cytokines. J. Leukoc. Biol. 68, 723-728.
20. Hilburger, M. E., Adler, M. W., Truant, A. L., Meissler, J. J., Satishchandran, V., Rogers, T. J., Eisenstein, T. K. (1997) Morphine induces sepsis in mice. J. Infect. Dis. 176, 183-188.
21. Roy, S., Charboneau, R. G., Barke, R. A. (1999) Morphine synergizes with lipopolysaccharide in a chronic endotoxemia model. J. Neuroimmunol. 95, 107-114.
22. West, J. P., Dykstra, L. A., Lysle, D. T. (1997) Tolerance development to morphine-induced alterations of immune status administration. Drug Alcohol Depend. 46, 147-157.
23. West, J. P., Dykstra, L. A., Lysle, D. T. (1998) Differential tolerance to morphine's immunomodulatory effects following continuous administration. Drug Alcohol Depend. 53, 31-38.
24. Chuang, L. F., Killam, K. F., Chuang, R. Y. (1993) Opioid dependency and T-helper cell functions in Rhesus monkey. In Vivo 7, 159-166.
25. Bayer, B. M., Hernandez, M. C., Ding, X. Z. (1996) Tolerance and crosstolerance to the suppressive effects of cocaine and morphine on lymphocyte proliferation. Pharmacol. Biochem. Behav. 53, 227-234.
26. Bayer, B. M., Brechio, R. M., Ding, X. Z., Hernandez, M. C. (1994) Enhanced susceptibility of the immune system to stress in morphine tolerant rats. Brain Behav. Immun. 8, 173-184.
27. Massi, P., Vaccani, A., Romorini, S., Parolaro, D. (2001) Comparative characterization in the rat of the interaction between cannabinoids and opiates for their immunosuppressive and analgesic effects. J. Neuroimmunol. 117, 116-124.
28. Bryant, H. U., Bernton, E. W., Holaday, J. W. (1988) Morphine pellet-induced immunomodulation in mice: temporal relationships. J. Pharmacol. Exp. Ther. 246, 913-920.
29. Bussiere, L. J., Adler, M. W., Rogers, T. J., Eisenstein, T. K. (1993) Cytokine reversal of morphine-induced suppression of the antibody response. J. Pharmacol. Exp. Ther. 264, 591-597.
30. Roy, S., Chapin, R. B., Cain, K. J., Charboneau, R. G., Ramakrishnan, S., Barke, R. A. (1997) Morphine inhibits transcriptional activation of IL-2 in mouse thymocytes. Cell. Immunol. 179, 1-9.
31. Bhargava, H. N., Thomas, P. T., Thorat, S., House, R. V. (1994) Effect of morphine tolerance and abstinence on cellular immune responses. Brain Res. 642, 1-10.
32. Roy, S., Balasubramanian, S., Sumandeep, S., Charnoneau, R., Wang, J., Melnyk, D., Vatassery, G. J., Barke, R. A. (2001) Morphine directs cells towards Th2 differentiation. Surgery 130, 304-309.
33. Madden, J. J., Whaley, W. L., Ketelsen, D., Donahoe, R. M. (2001) The morphine-binding site on human activated T-cells is not related to the mu opioid receptor. Drug Alcohol Depend. 62, 131-139.
34. McCarthy, L., Wetzel, M., Sliker, J. K., Eisenstein, T. K., Rogers, T. J. (2001) Opioids, opioid receptors and the immune response. Drug Alcohol Dep. 62, 111-123.
35. Sacerdote, P., Mantegazza, P., Panerai, A. E. (1985) Analgesic effects of mu antagonists after naloxone non-reversible stress induced analgesia. Brain Res. 359, 34-38.
36. Bianchi, M., Sacerdote, P., Locatelli, L., Mantegazza, P., Panerai, A. E. (1991) Corticotropin releasing hormone, interleukin 1-alpha, and tumor necrosis factor alpha share characteristics of stress mediators. Brain Res. 546, 139-142.
37. Bianchi, M., Panerai, A. E. (1993) Naloxone-induced analgesia; involvement of k-opiate receptors. Pharmacol. Biochem. Behav. 46, 145-148.
38. Levine, J. D., Gordon, N. C., Fields, H. L. (1979) Naloxone dose dependently produces analgesia and hyperalgesia in post-operative pain. Nature 278, 740-741.
39. Ferreira, S. H. (1980) Peripheral analgesia: mechanism of the analgesic action of aspirin-like drugs and opiate antagonists. Br. J. Clin. Pharmacol. 2, 237-245.